


Healthcare News Roundup: Drug Delivery
HSMN NewsFeed - 22 May 2007
Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDA
Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDA
HSMN NewsFeed - 21 May 2007
U.S. FDA Approves VELCADE(R) + DOXIL(R) Combination for Treatment of Relapsed/Refractory Multiple Myeloma
U.S. FDA Approves VELCADE(R) + DOXIL(R) Combination for Treatment of Relapsed/Refractory Multiple Myeloma
HSMN NewsFeed - 21 May 2007
Milestone Scientific Forms New Medical Division and Appoints Former Bayer Senior Executive as Its CEO
Milestone Scientific Forms New Medical Division and Appoints Former Bayer Senior Executive as Its CEO
HSMN NewsFeed - 16 May 2007
KV Pharmaceutical Company Completes Acquisition of U.S. Rights to EvaMist(TM)
KV Pharmaceutical Company Completes Acquisition of U.S. Rights to EvaMist(TM)
HSMN NewsFeed - 14 May 2007
Questcor Receives FDA Action Letter for H.P. Acthar(R) Gel for Treatment of Infantile Spasms
Questcor Receives FDA Action Letter for H.P. Acthar(R) Gel for Treatment of Infantile Spasms
HSMN NewsFeed - 14 May 2007
BDSI Announces Positive Key Secondary Efficacy Endpoint Results for BEMA(TM) Fentanyl
BDSI Announces Positive Key Secondary Efficacy Endpoint Results for BEMA(TM) Fentanyl
HSMN NewsFeed - 3 May 2007
Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device Combination Product - ChronoDose(TM)
Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device Combination Product - ChronoDose(TM)
HSMN NewsFeed - 25 Apr 2007
Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
HSMN NewsFeed - 25 Apr 2007
BDSI Announces Positive Phase III Clinical Trial Results for BEMA(TM) Fentanyl
BDSI Announces Positive Phase III Clinical Trial Results for BEMA(TM) Fentanyl
HSMN NewsFeed - 25 Apr 2007
OctoPlus Gains Full Rights to PolyActive Drug Delivery Technology From IsoTis
OctoPlus Gains Full Rights to PolyActive Drug Delivery Technology From IsoTis
HSMN NewsFeed - 23 Apr 2007
Generex Biotechnology Announces Middle Eastern Licensing Agreement for Generex Oral-lyn(TM)
Generex Biotechnology Announces Middle Eastern Licensing Agreement for Generex Oral-lyn(TM)
HSMN NewsFeed - 20 Apr 2007
Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
HSMN NewsFeed - 20 Apr 2007
FDA Grants Full Approval for DepoCyt(R) for the Treatment of Lymphomatous Meningitis
FDA Grants Full Approval for DepoCyt(R) for the Treatment of Lymphomatous Meningitis
HSMN NewsFeed - 19 Apr 2007
Antares Pharma Announces Positive Results from Application Site Study for ANTUROL(R)
Antares Pharma Announces Positive Results from Application Site Study for ANTUROL(R)
HSMN NewsFeed - 10 Apr 2007
Emisphere Technologies, Inc. Appoints Michael V. Novinski as President and Chief Executive Officer
Emisphere Technologies, Inc. Appoints Michael V. Novinski as President and Chief Executive Officer
